CompanyDeals

MediLink Licenses B7H3 ADC YL201 to Roche in $850 Million Global Deal

CompanyDrug

Shanghai MicuRx’s Contezolid Patent Extended Through 2033, Securing Market Exclusivity

CompanyDrug

Lilly’s Taltz-Zepbound Combo Meets Primary Endpoint in Psoriatic Arthritis

NMPA Issues New Rules to Strengthen Pharmaceutical Contract Manufacturing Oversight
Policy / Regulatory

NMPA Issues New Rules to Strengthen Pharmaceutical Contract Manufacturing Oversight

Betta Pharmaceuticals Partners with Westlake University on Pharma Innovation
CompanyDeals

Betta Pharmaceuticals Partners with Westlake University on Pharma Innovation

CompanyDeals

Viva Biotech and CMS Forge AI-Powered Drug Development Alliance

Hisun and ECNU Forge AI Drug Discovery Partnership
CompanyDeals

Hisun and ECNU Forge AI Drug Discovery Partnership

Policy / Regulatory

NMPA Issues Priority Review Guidelines for Clinically Urgent Overseas Drugs

Sciclon Licenses Augtyro Promotion Rights from Zai Lab for China Market
CompanyDeals

Sciclon Licenses Augtyro Promotion Rights from Zai Lab for China Market

Hengrui's Retlirafusp α Wins NMPA Approval for First-Line Gastric Cancer
CompanyDrug

Hengrui’s Retlirafusp α Wins NMPA Approval for First-Line Gastric Cancer

Pfizer Partners with Cartography on $850 Million Tumor Antigen Discovery Deal
CompanyDeals

Pfizer Partners with Cartography on $850 Million Tumor Antigen Discovery Deal

CompanyDrug

Sanofi’s Redemplo Wins NMPA Approval as First siRNA for Familial Chylomicronemia